Gufic Biosciences - Quaterly Results

09 Nov 2023 Evaluate
The company witnessed a 22.90% growth in the revenue at Rs. 2148.74 millions for the quarter ended September 2023 as compared to Rs. 1748.35 millions during the year-ago period.A humble growth in net profit of 14.83% reported in the quarter ended September 2023 to Rs. 232.10  millions from Rs. 202.12 millions.Operating Profit saw a handsome growth to 397.04 millions from 334.31 millions in the quarter ended September 2023.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202309 202209 % Var 202309 202209 % Var 202303 202203 % Var
Sales 2148.74 1748.35 22.90 4098.94 3401.11 20.52 6906.21 7791.56 -11.36
Other Income 3.34 8.18 -59.17 12.15 11.93 1.84 25.74 31.04 -17.07
PBIDT 397.04 334.31 18.76 760.63 669.85 13.55 1372.25 1511.34 -9.20
Interest 44.61 16.06 177.77 85.34 25.14 239.46 82.23 53.66 53.24
PBDT 352.43 318.25 10.74 675.29 644.71 4.74 1290.02 1457.68 -11.50
Depreciation 42.97 45.64 -5.85 85.33 89.29 -4.43 222.81 189.29 17.71
PBT 309.46 272.61 13.52 589.96 555.42 6.22 1067.21 1268.39 -15.86
TAX 77.36 70.49 9.75 151.62 142.78 6.19 270.16 309.98 -12.85
Deferred Tax 23.63 -6.51 -462.98 32.89 -7.82 -520.59 -11.94 -11.52 3.65
PAT 232.10 202.12 14.83 438.34 412.64 6.23 797.05 958.41 -16.84
Equity 96.94 96.94 0.00 96.94 96.94 0.00 96.94 96.94 0.00
PBIDTM(%) 18.48 19.12 -3.37 18.56 19.70 -5.78 19.87 19.40 2.44

Gufic Biosciences Share Price

345.80 -5.65 (-1.61%)
17-Dec-2025 10:35 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1775.25
Dr. Reddys Lab 1271.15
Cipla 1493.80
Zydus Lifesciences 917.60
Lupin 2114.00
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×